Belpointe Asset Management LLC Jazz Pharmaceuticals PLC Transaction History

Belpointe Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $62,032 - $74,297	-463 Reduced 34.14%	893 $130,000
Q4 2022 Feb 08, 2023	BUY	$129.72 - $159.85 $175,900 - $216,756	1,356 New	1,356 $216,000
Q1 2022 Apr 28, 2022	SELL	$129.64 - $160.7 $1.05 Million - $1.3 Million	-8,096 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$119.87 - $145.67 $970,467 - $1.18 Million	8,096 New	8,096 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $404,701 - $581,349	-3,146 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$160.2 - $186.42 $503,989 - $586,477	3,146 New	3,146 $559,000
Q1 2020 Jul 20, 2020	SELL	$87.74 - $152.74 $118,273 - $205,893	-1,348 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$117.65 - $153.73 $158,592 - $207,228	1,348 New	1,348 $201,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.